Raymond M. Jordt - 31 Jan 2025 Form 4 Insider Report for Altimmune, Inc. (ALT)

Signature
/s/ Greg Weaver as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
31 Jan 2025
Net transactions value
+$13,541
Form type
4
Filing time
03 Feb 2025, 20:45:33 UTC
Previous filing
28 Jan 2025
Next filing
04 Aug 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Award $13,541 +2,614 +8.1% $5.18 34,902 31 Jan 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2024 through January 31, 2025.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on August 1, 2024.